20 related articles for article (PubMed ID: 38537920)
1. Study of the anti-cancer activity of a mesoporous silica nanoparticle surface coated with polydopamine loaded with umbelliprenin.
Edalatian Tavakoli S; Motavalizadehkakhky A; Homayouni Tabrizi M; Mehrzad J; Zhiani R
Sci Rep; 2024 May; 14(1):11450. PubMed ID: 38769394
[TBL] [Abstract][Full Text] [Related]
2. Magnetic field activated drug delivery using thermodegradable azo-functionalised PEG-coated core-shell mesoporous silica nanoparticles.
Saint-Cricq P; Deshayes S; Zink JI; Kasko AM
Nanoscale; 2015 Aug; 7(31):13168-13172. PubMed ID: 26181577
[TBL] [Abstract][Full Text] [Related]
3. Targeted pH-responsive delivery of rosmarinic acid
Kawish M; Siddiqui NN; Jahan H; Elhissi A; Zahid H; Khatoon B; Raza Shah M
Pharm Dev Technol; 2024 May; ():1-10. PubMed ID: 38769920
[TBL] [Abstract][Full Text] [Related]
4. Characterization Methods for Nanoparticle-Skin Interactions: An Overview.
Dzyhovskyi V; Romani A; Pula W; Bondi A; Ferrara F; Melloni E; Gonelli A; Pozza E; Voltan R; Sguizzato M; Secchiero P; Esposito E
Life (Basel); 2024 May; 14(5):. PubMed ID: 38792620
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release.
Cui Y; Dong H; Cai X; Wang D; Li Y
ACS Appl Mater Interfaces; 2012 Jun; 4(6):3177-83. PubMed ID: 22646097
[TBL] [Abstract][Full Text] [Related]
6. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
Nasri N; Saharkhiz S; Dini G; Yousefnia S
Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
[TBL] [Abstract][Full Text] [Related]
7. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
8. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
Xie Z; Gong H; Liu M; Zhu H; Sun H
J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
[TBL] [Abstract][Full Text] [Related]
9. Aptamer Tethered Bio-Responsive Mesoporous Silica Nanoparticles for Efficient Targeted Delivery of Paclitaxel to Treat Ovarian Cancer Cells.
Salve R; Kumar P; Chaudhari BP; Gajbhiye V
J Pharm Sci; 2023 May; 112(5):1450-1459. PubMed ID: 36669561
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook.
Song Y; Li Y; Xu Q; Liu Z
Int J Nanomedicine; 2017; 12():87-110. PubMed ID: 28053526
[TBL] [Abstract][Full Text] [Related]
11. PEGylated mesoporous silica core-shell redox-responsive nanoparticles for delivering paclitaxel to breast cancer cells.
Shahbaz S; Esmaeili M; Fathian Nasab MH; Imani Z; Bafkary R; Amini M; Atyabi F; Dinarvand R
Int J Pharm; 2024 Apr; 655():124024. PubMed ID: 38537920
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
